![]() |
|
|
Forward to a colleague |
||
Access Full Stories Recipharm has come to rescue of UK-based Ashton Pharma, which has been nervously awaiting to discover its fate, having spent five months in administration after its former owners Inyx Inc. suffered major financial... Read New research offers CRO market snapshot New research from Frost & Sullivan provides a snapshot of biopharma spending trends on contract research organisations (CROs), along with forecasts for industry growth... Read Boehringer Ingelheim takes on prefilled syringes Boehringer Ingelheim has added to its contract services with the manufacture, fill and finish capacity for drugs in prefilled syringes... Read FMC improves on existing excipients FMC BioPolymer has introduced two new excipient products to the pharma market - the first in two years... Read Puerto Rico's problems piling up Pfizer's revelation this week that it plans to slice jobs in Puerto Rico is the latest in a string of blows for this popular offshore manufacturing location... Read |
||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||
Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here | ||||||||||||||
|
Related Industry News Mr Gene designs and orders constructs in minutes Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr Gene, which is targeting the emerging 'low-price' segment of the synthetic biology market... Read Take off immune system brake to improve cancer vaccines The discovery of a new molecule that can act as a brake for the immune system could lead to new therapies for cancer and autoimmune diseases such as diabetes... Read Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read Men get the heads up on possible oral contraceptive It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||